(Q33332758)

English

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

clinical oncology

1 reference

based on heuristic

inferred from title

author name string

K Kubota

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

T Tamura

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Fukuoka

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

K Furuse

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Ikegami

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Y Ariyoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Y Kurita

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Saijo

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

445-450

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008328207137

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008328207137

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33332758&oldid=1629446048"